Her husband's secret "business trip" was actually a corporate coup, funded by stolen medical data, but I already knew the coordinates of his private jet.
The late afternoon sun cast long shadows across the polished floors of Innovision Health as I made my way to Dr. Elena Petrova’s lab. My heart hammered against my ribs with a mix of fear and grim determination. Trusting someone else with this evidence, even someone as ethically sound as Dr. Petrova, felt like a massive risk. But it was a necessary one.
I found Dr. Petrova hunched over a microscope, her focus absolute. She looked up, her expression shifting from scientific intensity to mild surprise at seeing me.
“Amara. This is an unexpected visit,” she said, removing her safety glasses. “Everything alright?”
“Not exactly, Elena,” I replied, my voice low, glancing around the empty lab. “I need your expertise, discreetly.”
I briefly explained the situation: Julian’s suspicious corporate maneuvering, the shell company, and the disturbing discrepancies in Nia Washington’s financials. I handed her the envelope containing Nia’s unredacted medical record.
“This is Nia Washington’s personal medical history,” I explained, my voice barely a whisper. “Marcus, my brother, obtained it. We believe Julian coerced her into providing it for a ‘personalized therapy’ he promised her.”
Dr. Petrova’s brow furrowed as she took the envelope. She was a woman of science, of facts, and the idea of exploiting a patient’s data would be an anathema to her.
“Coerced?” she asked, her voice sharp with concern.
“He targeted her rare autoimmune condition, promising a cure,” I elaborated. “But her original consent form explicitly states her data was for general research only, anonymized. Never for a commercial personalized therapy or transfer to a private entity.”
Dr. Petrova’s gaze hardened as she quickly scanned the consent form. “This is highly unethical, Amara. If true, it’s a blatant violation of patient trust and research ethics.”
“It gets worse,” I continued, then presented her with printouts of Julian’s shell company’s patent applications, which Aisha had procured. “I need you to cross-reference the unique biomarkers detailed in Nia’s medical record with the scientific language used in these patent filings.”
She looked at the two sets of documents, her brilliant mind already making connections. “You suspect he used her unique biology to secure patents for his own gain?”
“We don’t suspect, Elena. We need to prove it,” I stated, my eyes meeting hers. “Julian plans to unveil a new venture at the Innovision board meeting tomorrow. We believe it’s built on these fraudulent patents. If we can’t prove this connection, he will walk away with a fortune, and Nia will be a victim, along with Innovision.”
Dr. Petrova didn’t hesitate. She placed both sets of documents on a clean lab bench, her attention already focused. She scrolled through Nia’s complex genetic markers, her unique protein expressions, the detailed biological fingerprint of her rare condition. Then, she opened the patent applications, her fingers flying across the screen, searching databases, cross-referencing terminology. The lab was silent save for the soft hum of equipment and the click of her mouse.
Minutes stretched into what felt like an eternity. I watched her face, searching for any sign, any reaction. Her expression remained unreadable, a mask of pure scientific concentration. Then, her eyes widened. Her jaw tightened visibly.
She pointed to a specific sequence in Nia’s medical record, then to a paragraph in one of Julian’s patent applications.
“Here,” she said, her voice strained, a raw edge of professional outrage in her tone. “These specific genetic variants. These protein sequences. They are incredibly rare, Amara. Unique to a very small subset of patients with Nia’s exact condition.”
She slammed her hand lightly on the patent document. “And here, in Julian’s patent application for ‘Novel Immunomodulatory Compounds,’ he describes a ‘proprietary therapeutic target’ that precisely matches these unique biomarkers. He’s claiming *her* unique biology as his own discovery.”
My breath hitched. The hidden connection. The final, damning piece of the puzzle. Julian hadn’t just stolen data; he had stolen Nia’s very essence, repackaged it, and was attempting to profit from it.
“He didn’t just ‘acquire’ data, Amara,” Dr. Petrova continued, her voice shaking with quiet fury. “He reverse-engineered Nia’s unique biological signature. He filed patents on her *life*, on the very markers that define her illness, under the guise of helping her. This is beyond unethical. This is criminal.”
Her face was pale with shock, a deep sense of betrayal evident in her eyes. “Innovision’s reputation… this could destroy everything we’ve built. The trust of our patients, our researchers… it’s all compromised.”
“He painted a picture of a breakthrough, Elena,” I explained, “a personalized therapy for Nia. He even paid her a quarter of a million dollars as a ‘consulting fee’ to keep her quiet, to make her feel like a partner.”
Dr. Petrova shook her head in disbelief. “A personalized therapy using *her* biomarkers in a patent he owns? That’s not a therapy, Amara. That’s pure exploitation. He was banking on her belief, on her hope, to keep her from questioning him.”
“We have to stop him,” I said, my voice resolute. “He plans to announce this ‘new venture’ at the board meeting tomorrow. This evidence, combined with Nia’s record, is irrefutable. It proves Julian’s entire scheme.”
“What do you need me to do?” Dr. Petrova asked, her eyes blazing with determination. “I will sign an affidavit. I will testify. My ethical duty demands it.”
“Not yet,” I cautioned. “Julian still has considerable influence. A direct accusation from you now might be dismissed as internal politics, especially with the rumors he’s spread about me. We need a direct confrontation first, with him, armed with all of this. The board needs to see his reaction, his unraveling, not just a document.”
“You plan to confront him directly?” she asked, a hint of concern in her tone. “He is a formidable opponent, Amara.”
“He thinks I’m a distraction,” I stated, a grim satisfaction in my voice. “He thinks he’s playing a game of corporate chess. He has no idea I’ve collected all the pieces to checkmate him.”
I carefully gathered the documents, my fingers tracing the lines of the patent applications that now felt like a grotesque mockery of science. Dr. Petrova’s confirmation was the final, definitive link. Julian’s entire empire was built on a foundation of stolen data and ethical fraud. My quiet methodical nature had been underestimated for too long. Tomorrow, Julian would learn the true cost of his arrogance. Tomorrow, the reckoning would begin.
More Stories
+ There are no comments
Add yours